SOURCE: INC Research

INC Research

January 18, 2011 07:30 ET

INC Research Adds AVOS Life Sciences to Strengthen Strategic and Regulatory Consulting Group

Powerhouse Team Expands Consulting Capabilities With Unparalleled Expertise and Analytical Tools

RALEIGH, NC--(Marketwire - January 18, 2011) -   INC Research, LLC., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, today announced that it has acquired the team and research products of AVOS Life Sciences. The new division of INC Research, now called AVOS Consulting, delivers strategic, operational and financial analysis to help life sciences companies successfully compete in an increasingly challenging global environment. AVOS will operate as an autonomous division within INC Research reporting directly to the chief executive officer, James Ogle,

"We are very pleased to welcome this esteemed group of experts to the INC Research family," said Ogle. "The addition of the team members and their proven analytical tools will provide immediate value to our existing customers and significantly contribute to our alliance partnerships efforts."

AVOS offers independent perspectives on the future business environment for healthcare products and services to pharmaceutical, biotech, device and diagnostic companies. Key executives from AVOS, which includes Neil MacAllister, Keith Ruark, Kathleen Griffin, and David Ewbank, have a solid reputation for providing insights into areas such as healthcare trend assessment, business model development, capital allocation, portfolio optimization, accelerated drug development models and pricing and market access.

"Our understanding of the complex healthcare industry and the deep therapeutic foresight within INC Research is a powerful combination to develop new approaches to global drug development and commercialization efforts," said MacAllister, president of AVOS Consulting and executive vice president of INC Research. "For example, we work with customers to reach proof of concept faster and at lower cost while carrying these efficiencies over to the later stages of clinical development."

In addition to providing consulting expertise, members of the AVOS team will dedicate support to INC Research's innovative Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances. This new approach to sponsor-CRO relationships is designed to drive maximum value for development programs through resource flexibility, corporate efficiency and risk mitigation. 

AVOS Consulting is located at the new INC Research headquarters in Raleigh, NC. For further information, contact Kathleen Griffin at

About INC Research, LLC.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women's health trials. The company's Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information please visit or follow us at @inc_research

Contact Information